Terms: = Prostate cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF AND Diagnosis
12 results:
1. Can frailty scores predict the incidence of cancer? Results from two large population-based studies.
Mak JKL; Kuja-Halkola R; Wang Y; Hägg S; Jylhävä J
Geroscience; 2023 Jun; 45(3):2051-2064. PubMed ID: 36997701
[TBL] [Abstract] [Full Text] [Related]
2. Differentiating benign and malignant pancreatic masses: Ga-68 PSMA PET/CT as a new diagnostic avenue.
Krishnaraju VS; Kumar R; Mittal BR; Sharma V; Singh H; Nada R; Bal A; Rohilla M; Singh H; Rana SS
Eur Radiol; 2021 Apr; 31(4):2199-2208. PubMed ID: 33001304
[TBL] [Abstract] [Full Text] [Related]
3. A dual-round signal amplification strategy for colorimetric/photoacoustic/fluorescence triple read-out detection of prostate specific antigen.
Jiang C; Huang Y; He T; Huang P; Lin J
Chem Commun (Camb); 2020 May; 56(36):4942-4945. PubMed ID: 32239063
[TBL] [Abstract] [Full Text] [Related]
4. Role of
Budak E; Yanarateş A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(1):14-19. PubMed ID: 31744788
[TBL] [Abstract] [Full Text] [Related]
5. Comparison of PET/MRI with multiparametric MRI in diagnosis of primary prostate cancer: A meta-analysis.
Li M; Huang Z; Yu H; Wang Y; Zhang Y; Song B
Eur J Radiol; 2019 Apr; 113():225-231. PubMed ID: 30927951
[TBL] [Abstract] [Full Text] [Related]
6. Performance of urinary survivin as a non-invasive molecular marker of bladdercarcinoma in a schistosomiasis endemic area.
Muhammad AS; Mungadi IA; Ndodu ED; Kalayi GD
Ghana Med J; 2018 Jun; 52(2):74-78. PubMed ID: 30662078
[TBL] [Abstract] [Full Text] [Related]
7. [PRIMARY SQUAMOUS CELL CARCINOMA OF THE prostate: A CASE REPORT].
Fukui K; Nagasawa S; Hanasaki T; Ueda Y; Aihara K; Kokura K; Matsuo S; Zozumi M; Tsukamoto Y
Nihon Hinyokika Gakkai Zasshi; 2019; 110(2):129-133. PubMed ID: 32307381
[TBL] [Abstract] [Full Text] [Related]
8. Computer-aided diagnosis of prostate cancer using multi-parametric MRI: comparison between PUN and Tofts models.
Mazzetti S; Giannini V; Russo F; Regge D
Phys Med Biol; 2018 May; 63(9):095004. PubMed ID: 29570456
[TBL] [Abstract] [Full Text] [Related]
9. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract] [Full Text] [Related]
10. A fully automatic computer aided diagnosis system for peripheral zone prostate cancer detection using multi-parametric magnetic resonance imaging.
Giannini V; Mazzetti S; Vignati A; Russo F; Bollito E; Porpiglia F; Stasi M; Regge D
Comput Med Imaging Graph; 2015 Dec; 46 Pt 2():219-26. PubMed ID: 26391055
[TBL] [Abstract] [Full Text] [Related]
11. Self-Reported Health Status Predicts Other-Cause Mortality in Men with Localized prostate cancer: Results from the prostate cancer Outcomes Study.
Hoffman RM; Koyama T; Albertsen PC; Barry MJ; Daskivich TJ; Goodman M; Hamilton AS; Stanford JL; Stroup AM; Potosky AL; Penson DF
J Gen Intern Med; 2015 Jul; 30(7):924-34. PubMed ID: 25678374
[TBL] [Abstract] [Full Text] [Related]
12. [Diagnostic performance of bone scintigraphy and (11)C-Choline PET/CT in the detection of bone metastases in patients with biochemical recurrence of prostate cancer].
Garcia JR; Moreno C; Valls E; Cozar P; Bassa P; Soler M; Alvarez-Moro FJ; Moragas M; Riera E
Rev Esp Med Nucl Imagen Mol; 2015; 34(3):155-61. PubMed ID: 25443648
[TBL] [Abstract] [Full Text] [Related]
